Enhanced in vitro cytotoxicity and cytostasis of the combination of onconase with a proteasome inhibitorMIKULSKI, S. M; VIERA, A; DEPTALA, A et al.International journal of oncology. 1998, Vol 13, Num 4, pp 633-644, issn 1019-6439Article

Differences in induction of p53, p21^WAF1 and apoptosis in relation to cell cycle phase of mcf-7 cells treated with camptothecinDEPTALA, A; XUN LI; BEDNER, E et al.International journal of oncology. 1999, Vol 15, Num 5, pp 861-871, issn 1019-6439Article

Radioimmunotherapy with ⁹⁰Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-NetworkHOHLOCH, K; ZINZANI, P. L; LINKESCH, W et al.Bone marrow transplantation (Basingstoke). 2011, Vol 46, Num 6, pp 901-903, issn 0268-3369, 3 p.Article

Telomere shortening is an in vivo marker of myocyte replication and agingKAJSTURA, J; PERTOLDI, B; LERI, A et al.The American journal of pathology. 2000, Vol 156, Num 3, pp 813-819, issn 0002-9440Article

Clinical and laboratory evaluation of all-trans retinoic acid modulation of chemotherapy in patients with acute myelogenous leukaemiaSEITER, K; FELDMAN, E. J; DARZYNKIEWICZ, Z et al.British journal of haematology. 2000, Vol 108, Num 1, pp 40-47, issn 0007-1048Article

Potentiation of tumor necrosis factor induced apoptosis by onconaseDEPTALA, A; HALICKA, H. D; ARDELT, B et al.International journal of oncology. 1998, Vol 13, Num 1, pp 11-16, issn 1019-6439Article